URMC Research Network

Find People
Keyword
Last Name
 
More Search Options

Yuhchyau Chen

Concepts (269)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of pubs Most recent pub Pubs by all authors Concept score Why?
Carcinoma, Non-Small-Cell Lung
12
2001
72
4.920
Why?
Lung Neoplasms
13
2001
439
4.330
Why?
Reticulocytes
8
2003
45
4.150
Why?
Paclitaxel
6
2001
58
2.340
Why?
Micronuclei, Chromosome-Defective
4
2007
21
2.270
Why?
Radiation-Sensitizing Agents
5
2001
75
2.240
Why?
Radiation Pneumonitis
6
2001
44
1.710
Why?
Neoplasms
8
2003
739
1.590
Why?
Gamma Rays
3
2009
69
1.520
Why?
Thoracic Neoplasms
4
2001
19
1.410
Why?
Antineoplastic Agents, Phytogenic
3
2003
40
1.340
Why?
Bone Marrow Cells
2
2009
221
1.330
Why?
Micronucleus Tests
6
2003
25
1.280
Why?
Flow Cytometry
12
1988
603
1.150
Why?
Dose-Response Relationship, Radiation
9
2003
219
1.030
Why?
Fibroblast Growth Factor 7
2
2011
11
1.030
Why?
Radiation Injuries, Experimental
3
2005
90
0.970
Why?
Whole-Body Irradiation
4
1999
83
0.960
Why?
Interleukin-6
4
2001
339
0.850
Why?
Chemoradiotherapy
1
2012
1
0.830
Why?
Radiation Oncology
2
2006
18
0.820
Why?
Deglutition Disorders
1
2012
21
0.820
Why?
Middle Aged
22
2001
9837
0.790
Why?
Laryngeal Neoplasms
1
2011
19
0.790
Why?
Chromosome Aberrations
3
2003
115
0.770
Why?
Aged
17
2001
7269
0.750
Why?
Radiotherapy
5
2003
198
0.740
Why?
Taxoids
1
2010
14
0.740
Why?
Combined Modality Therapy
5
2003
486
0.740
Why?
Aged, 80 and over
12
2001
2529
0.730
Why?
Cell Cycle
9
1988
254
0.710
Why?
Radiometry
1
2010
40
0.710
Why?
Biological Assay
1
2010
70
0.700
Why?
Radiotherapy Dosage
9
2001
203
0.700
Why?
Adult
22
1988
11351
0.690
Why?
Female
27
1988
19838
0.690
Why?
Carcinoma, Squamous Cell
1
2011
236
0.680
Why?
Pneumonectomy
2
2008
14
0.680
Why?
Neoplastic Stem Cells
1
2009
40
0.670
Why?
Palliative Care
2
2010
159
0.660
Why?
Humans
41
1988
36274
0.660
Why?
Radiation Injuries
3
2006
131
0.660
Why?
Male
24
1988
19675
0.630
Why?
Clinical Trials as Topic
2
2004
671
0.610
Why?
Cesium Radioisotopes
1
2007
29
0.600
Why?
Biological Markers
6
2001
560
0.600
Why?
Biomedical Research
1
2009
139
0.580
Why?
Treatment Outcome
10
2008
2615
0.570
Why?
Automation
1
2006
31
0.570
Why?
Interleukin-1
2
2002
218
0.560
Why?
Nuclear Energy
1
2006
3
0.550
Why?
Radiobiology
1
2006
10
0.550
Why?
International Agencies
1
2006
9
0.540
Why?
Cytokines
3
2002
565
0.490
Why?
Dose Fractionation
4
2009
60
0.440
Why?
Mice
11
1990
6111
0.430
Why?
Antineoplastic Combined Chemotherapy Protocols
3
2009
429
0.420
Why?
Genetic Testing
1
2003
96
0.420
Why?
Drug Administration Schedule
3
2001
366
0.410
Why?
Oxygen
1
2005
493
0.400
Why?
Neoplasm Staging
4
2008
338
0.380
Why?
Platelet-Derived Growth Factor
3
1989
108
0.380
Why?
Neoplasms, Experimental
1
2001
145
0.380
Why?
Epidermal Growth Factor
3
1989
112
0.380
Why?
Severity of Illness Index
3
2006
922
0.370
Why?
Bioreactors
2
2009
8
0.370
Why?
Animals
15
1990
16093
0.370
Why?
Genetic Predisposition to Disease
1
2003
331
0.360
Why?
Somatomedins
2
1989
14
0.360
Why?
Follow-Up Studies
4
2001
1855
0.330
Why?
Insulin-Like Growth Factor I
2
1989
104
0.330
Why?
Head and Neck Neoplasms
2
2007
83
0.330
Why?
Retrospective Studies
6
2008
2267
0.320
Why?
Cell Survival
2
1990
551
0.310
Why?
Radiosurgery
2
2009
74
0.310
Why?
Cells, Cultured
7
1988
2479
0.310
Why?
Antineoplastic Agents
5
2003
619
0.310
Why?
Tumor Necrosis Factor-alpha
2
2001
659
0.300
Why?
DNA Damage
4
2003
170
0.290
Why?
Enzyme-Linked Immunosorbent Assay
3
2001
462
0.290
Why?
Mitosis
2
1990
99
0.290
Why?
Fibroblasts
3
1988
534
0.290
Why?
Cisplatin
3
2009
95
0.270
Why?
Mice, Inbred C57BL
3
2009
1675
0.260
Why?
Survival Rate
4
2009
618
0.260
Why?
Tumor Cells, Cultured
3
2001
881
0.260
Why?
Sensitivity and Specificity
2
2005
905
0.240
Why?
Tumor Markers, Biological
2
2003
229
0.240
Why?
Time Factors
5
1989
3182
0.230
Why?
Proportional Hazards Models
3
2008
450
0.230
Why?
Pyrazoles
2
2003
57
0.230
Why?
Tomography, X-Ray Computed
3
2003
759
0.230
Why?
Hydrazines
1
2012
12
0.210
Why?
Receptors, Thrombopoietin
1
2012
9
0.210
Why?
Benzoates
1
2012
14
0.210
Why?
Survival Analysis
2
2011
606
0.210
Why?
Double-Blind Method
2
2011
992
0.210
Why?
Disease Progression
2
2009
521
0.210
Why?
Skin
2
1989
377
0.200
Why?
Carboplatin
1
2012
30
0.200
Why?
Population
1
2011
10
0.200
Why?
Stomatitis
1
2011
16
0.200
Why?
Thrombocytopenia
1
2012
74
0.200
Why?
Disease-Free Survival
1
2012
198
0.200
Why?
SEER Program
1
2011
53
0.190
Why?
Recombinant Proteins
2
2010
723
0.190
Why?
Kaplan-Meier Estimate
1
2012
222
0.190
Why?
Culture Media
2
1988
195
0.190
Why?
Erythroid Cells
1
2011
20
0.190
Why?
Tumor Stem Cell Assay
1
2010
24
0.190
Why?
Stem Cell Transplantation
1
2012
110
0.190
Why?
Magnetic Resonance Spectroscopy
1
1992
241
0.180
Why?
Bromodeoxyuridine
4
1988
66
0.180
Why?
Granulocyte Colony-Stimulating Factor
1
2010
44
0.180
Why?
Nausea
2
2007
155
0.180
Why?
Remission Induction
1
2010
161
0.180
Why?
Neoplasm Recurrence, Local
2
2009
288
0.180
Why?
Erythropoiesis
1
2010
62
0.180
Why?
Translational Medical Research
1
2010
38
0.180
Why?
Cell Line, Tumor
2
2003
575
0.180
Why?
Neoplastic Cells, Circulating
1
2009
7
0.170
Why?
Radiation Dosage
1
2010
125
0.170
Why?
Information Dissemination
1
2009
24
0.170
Why?
Acupressure
1
2009
16
0.170
Why?
Drug Resistance, Neoplasm
1
2009
56
0.170
Why?
Adrenal Gland Neoplasms
1
2009
35
0.170
Why?
Cell Hypoxia
1
2009
89
0.160
Why?
Pilot Projects
1
2010
442
0.160
Why?
Prospective Studies
2
2001
1689
0.160
Why?
Kinetics
2
1988
1391
0.160
Why?
Smoking
2
2008
399
0.160
Why?
Infusions, Intravenous
1
2008
143
0.160
Why?
Quinuclidines
1
2007
5
0.150
Why?
Muscarinic Agonists
1
2007
20
0.150
Why?
Cohort Studies
1
2011
969
0.150
Why?
Thiophenes
1
2007
17
0.150
Why?
Xerostomia
1
2007
42
0.150
Why?
Hematopoietic Stem Cells
1
2009
197
0.150
Why?
Bisbenzimidazole
3
1988
9
0.140
Why?
Antigens, Differentiation, B-Lymphocyte
2
2003
51
0.140
Why?
Reproducibility of Results
1
2010
877
0.140
Why?
Dictionaries as Topic
1
2006
1
0.140
Why?
Radiation-Protective Agents
1
2006
41
0.130
Why?
Lung
2
1988
1159
0.130
Why?
New York
1
2010
1305
0.130
Why?
Age Factors
1
2009
1128
0.130
Why?
Antigens, CD
2
2003
244
0.130
Why?
Spectroscopy, Near-Infrared
1
2005
12
0.130
Why?
Terminology as Topic
1
2006
109
0.130
Why?
Cell Differentiation
1
2011
1093
0.120
Why?
ROC Curve
1
2005
126
0.120
Why?
History, 21st Century
1
2005
47
0.120
Why?
Apoptosis
3
2003
823
0.120
Why?
Intestines
1
2005
154
0.120
Why?
Research
1
2005
178
0.120
Why?
Anoxia
1
2005
159
0.110
Why?
History, 20th Century
1
2005
244
0.110
Why?
Information Services
1
2003
22
0.110
Why?
Maximum Tolerated Dose
1
2003
17
0.110
Why?
United States
1
2011
2688
0.110
Why?
G2 Phase
1
2003
30
0.110
Why?
Cyclooxygenase Inhibitors
1
2003
66
0.110
Why?
Predictive Value of Tests
1
2005
606
0.110
Why?
Sulfonamides
1
2003
102
0.110
Why?
Surgical Procedures, Operative
1
2003
111
0.100
Why?
Models, Biological
1
2007
1008
0.100
Why?
Transplantation, Heterologous
1
2001
92
0.100
Why?
Necrosis
1
2001
103
0.100
Why?
Neoplasm Transplantation
1
2001
192
0.100
Why?
Mesothelioma
1
2001
30
0.100
Why?
Postoperative Complications
1
2006
733
0.100
Why?
Isoenzymes
1
2003
439
0.090
Why?
Risk Factors
2
2002
2345
0.090
Why?
Prognosis
1
2003
1083
0.090
Why?
Transplantation Conditioning
1
1999
33
0.090
Why?
Cyclophosphamide
1
1999
174
0.080
Why?
Fibroblast Growth Factor 2
1
1999
83
0.080
Why?
Bone Marrow Transplantation
1
1999
197
0.080
Why?
Dose-Response Relationship, Drug
2
1990
1117
0.070
Why?
Comorbidity
2
2008
380
0.070
Why?
Breast Neoplasms
1
2003
673
0.070
Why?
Transplantation, Homologous
2
1999
276
0.070
Why?
Ethidium
1
1994
14
0.060
Why?
Receptors, Transferrin
2
2003
21
0.060
Why?
Staining and Labeling
2
1990
162
0.060
Why?
Platelet Count
1
2012
50
0.050
Why?
Tissue Survival
1
1992
5
0.050
Why?
Phosphocreatine
1
1992
13
0.050
Why?
Organophosphorus Compounds
1
1992
24
0.050
Why?
Hydrogen
1
1992
29
0.050
Why?
Transplantation, Autologous
1
2012
144
0.050
Why?
Fatal Outcome
1
2012
104
0.050
Why?
Models, Anatomic
1
1992
39
0.050
Why?
Phosphorus
1
1992
48
0.050
Why?
Intention to Treat Analysis
1
2011
9
0.050
Why?
Drug Toxicity
1
2011
16
0.050
Why?
Cell Separation
2
1988
231
0.050
Why?
BH3 Interacting Domain Death Agonist Protein
1
2011
12
0.050
Why?
Phosphates
1
1992
147
0.050
Why?
Ischemia
1
1992
87
0.050
Why?
Rats, Inbred F344
1
1992
360
0.050
Why?
Diploidy
1
1990
13
0.050
Why?
bcl-2-Associated X Protein
1
2011
56
0.050
Why?
Weight Loss
1
2011
74
0.050
Why?
Rats, Inbred Strains
1
1992
650
0.050
Why?
bcl-X Protein
1
2011
41
0.050
Why?
Erythroblasts
1
2011
39
0.050
Why?
Equipment Design
1
1992
248
0.050
Why?
Mitogens
1
1990
36
0.050
Why?
Surgical Flaps
1
1992
114
0.050
Why?
Rats
2
1992
4289
0.050
Why?
Neoplasm Metastasis
1
2011
228
0.050
Why?
Image Enhancement
1
1992
145
0.040
Why?
Cell Count
1
1990
286
0.040
Why?
Transferrin
1
1989
38
0.040
Why?
Etoposide
1
2009
83
0.040
Why?
Markov Chains
1
2009
40
0.040
Why?
Cell Communication
1
1990
139
0.040
Why?
Tumor Burden
1
2009
22
0.040
Why?
Recurrence
1
2011
691
0.040
Why?
Gastrointestinal Tract
1
2009
26
0.040
Why?
Cell Division
3
1988
762
0.040
Why?
Fluorescent Dyes
1
1990
226
0.040
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2011
542
0.040
Why?
Dexamethasone
1
1989
181
0.040
Why?
Vomiting
1
2009
115
0.040
Why?
Benzimidazoles
1
1988
21
0.040
Why?
Biopsy
1
1989
362
0.040
Why?
Dyspepsia
1
2007
2
0.040
Why?
Sweat
1
2007
7
0.040
Why?
Diarrhea
1
2007
66
0.040
Why?
Pulmonary Fibrosis
1
1988
140
0.040
Why?
Insulin
1
1990
668
0.040
Why?
Logistic Models
1
2009
611
0.040
Why?
Incidence
1
2008
685
0.030
Why?
Transforming Growth Factor beta3
1
2005
4
0.030
Why?
Transforming Growth Factor beta2
1
2005
5
0.030
Why?
Algorithms
1
2009
541
0.030
Why?
Kidney
1
2009
586
0.030
Why?
Mice, Inbred DBA
1
2005
92
0.030
Why?
Gene Expression Regulation
1
2011
888
0.030
Why?
Risk Assessment
1
2009
884
0.030
Why?
Transforming Growth Factor beta1
1
2005
76
0.030
Why?
DNA
1
1990
845
0.030
Why?
Young Adult
1
2009
1059
0.030
Why?
Propidium
1
2004
4
0.030
Why?
Cytogenetic Analysis
1
2004
21
0.030
Why?
Splenectomy
1
2003
35
0.030
Why?
Splenic Diseases
1
2003
15
0.030
Why?
Antimetabolites, Antineoplastic
1
2004
40
0.030
Why?
Pregnancy
1
1989
1966
0.030
Why?
Drug Screening Assays, Antitumor
1
2003
36
0.030
Why?
Fluorouracil
1
2004
78
0.030
Why?
Xenograft Model Antitumor Assays
1
2003
47
0.030
Why?
Cyclooxygenase 2 Inhibitors
1
2003
63
0.030
Why?
Interferon-gamma
1
2005
348
0.030
Why?
Transforming Growth Factor beta
1
2005
412
0.030
Why?
Cyclooxygenase 2
1
2003
226
0.030
Why?
Prostaglandin-Endoperoxide Synthases
1
2003
169
0.030
Why?
Rats, Sprague-Dawley
1
2004
986
0.020
Why?
Membrane Proteins
1
2003
540
0.020
Why?
RNA, Messenger
1
2005
1863
0.020
Why?
Data Display
1
1990
13
0.010
Why?
Reference Standards
1
1990
45
0.010
Why?
Fluorescence
1
1990
73
0.010
Why?
Microcomputers
1
1988
10
0.010
Why?
Fluorescent Antibody Technique
1
1988
283
0.010
Why?
Lymphocytes
1
1988
291
0.010
Why?
Lymphocyte Activation
1
1988
410
0.010
Why?

Visualizations


Chen's Networks

Concepts
_
Co-Authors
_
Similar People
_
Same Department